A 2019 rule change by the U.S. medical devices regulator aimed at encouraging innovations targeting insomnia and anxiety is bearing fruit: Neurovalens, a Belfast-based startup that for over a decade has been developing technology to deliver noninvasive electrical stimulation of the brain and nervous system, has just had its second head-mounted treatment device cleared by the FDA.

Neurovalens now has two medical devices approved for prescription by doctors in the U.S.: one to treat generalized anxiety disorder (GAD) and another targeting insomnia. Its GAD device was approved just last week, and its device for insomnia received FDA clearance last October. More products are on the way, including a device for treating obesity-related cardiometabolic risk, which targets brain messaging that can influence the storage of harmful visceral fat. It’s next in the pipeline.

#MEDITATION (mindfulness) #Gadgets #Sleep 

Neurotech startup Neurovalens gets FDA clearance for noninvasive anxiety treatment | TechCrunch

MEDITATION (mindfulness)

Gadgets

Sleep

A 2019 rule change by the U.S. medical devices regulator aimed at encouraging innovations targeting insomnia and anxiety is bearing fruit: Neurovalens, a Belfast-based startup that for over a decade has been developing technology to deliver noninvasive electrical stimulation of the brain and nervous system, has just had its second head-mounted treatment device cleared by the FDA.  Neurovalens now has two medical devices approved for prescription by doctors in the U.S.: one to treat generalized anxiety disorder (GAD) and another targeting insomnia. Its GAD device was approved just last week, and its device for insomnia received FDA clearance last October. More products are on the way, including a device for treating obesity-related cardiometabolic risk, which targets brain messaging that can influence the storage of harmful visceral fat. It’s next in the pipeline.  #MEDITATION (mindfulness) #Gadgets #Sleep  Neurotech startup Neurovalens gets FDA clearance for noninvasive anxiety treatment | TechCrunch A 2019 rule change by the U.S. medical devices regulator aimed at encouraging innovations targeting insomnia and anxiety is bearing fruit: Neurovalens, a Neurovalens, a Belfast-based startup that's be https://techcrunch.com/2024/04/08/neurovalens-anxiety-fda/?utm_source=substack&utm_medium=email

Jerome Cody

sounds like  Electric Xanax!

I mean some noninvasive physically harmless cocaine would boost productivity 10 fold ... For the development of ASI and peace in utopia of course 🫡🤥🫠😜

sounds like  Electric Xanax!  I mean some noninvasive physically harmless cocaine would boost productivity 10 fold ... For the development of ASI and peace in utopia of course 🫡🤥🫠😜

Cyril

We are entering the era of bio/acc 😁

Very bullish for it

We are entering the era of bio/acc 😁  Very bullish for it